There is a significant unmet need for additional treatment options for high-grade NMIBC, especially in those ineligible for BCG.
CRE Investment Sentiment Strengthens, Retail Performance Maintains Stability Residential Market: The sustained low-interest-rate environment and wealth effects from ...
As part of Yahoo Finance's exclusive coverage with executives at Apollo Global (APO), Yahoo Finance Executive Editor Brian ...
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden ...
XmAb819 demonstrated a manageable safety profile with primarily grade 1 or 2 cytokine release syndrome and no neurotoxicity in ccRCC patients. The trial involved 69 patients, with a 25% objective ...
Figure 8: Striplog RIBS-DD-001 showing mineralized interval with composite uranium mineralization 1 with average grades - ...
Bungie releases a major new update for Destiny 2 Renegades, fixing bugs, adding quality of life adjustments, and a requested ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...
The 2.2 MW initial capacity, with expansion potential to 4.3 MW, provides AlphaTON with the power infrastructure to deploy thousands of enterprise-grade GPUs across multiple computing clusters. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback